Open Access

Table 1

Patient characteristics.

No. Sex Age (years) Diagnosis Size (cm) (resected tumor) Grade (resected tumor) Adjuvant Reason for TFR
1 M 33 OS 18 × 4 × 3 I Primary tumor
2 M 27 OS Unknown III Unknown Loosening-D/F
3 M 29 Ewing’s sarcoma Unknown III C Infection-Rad bone
4 F 14 OS 6 × 4 × 3 III C + R LR-D/F
5 F 79 Myxofibrosarcoma 18.5 × 12 × 8 III R Primary tumor
6 M 58 UPS 27.5 × 14 × 10 III C + R Primary tumor
7 F 72 UPS 16 × 10 × 8 III R LR
8 M 67 UPS 6.5 × 5 × 3.5 + 4 × 3 × 2.5 III C + R LR-P/F
9
F
49
Metastatic bone tumor (breast)
11 × 3 × 2.5
III
C
LR-P/F
Mean

47.5





No. Complication ROM
MMT
Gait MSTS score (%) Status (months)


Extension (°)
Flexion (°)
Extension (°)
1 0 50 5 Without crutches 80 CDF (104)
2 0 100 3 Without crutches 46.7 CDF (206)
3 −30 90 2 T cane 73.3 CDF (200)
4 0 45 3 Single crutch 63.3 AWD (41)
5 DVT 0 80 3 T cane 53.3 DOD (90)
6 DVT / / 2 Without crutches 70 DOD (46)
7 0 90 2 T cane 33.3 DOD (92)
8 Infection 0 100 2 T cane 46.7 DOD (28)
9 0 90 4 Lofstrand 60 AWD (48)
Mean 3.8 80.6 2.9 58.5

OS, osteosarcoma; UPS, undifferentiated pleomorphic sarcoma; C, chemotherapy; R, radiotherapy; LR, local recurrence; D/F, distal femur; P/F, proximal femur; DVT, deep venous thrombosis; CDF, continuous disease-free status; AWD, alive with disease; DOD, died of disease.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.